www.2020optimeyes.ca
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
pre-seed
Fund:
Prospects
Next-generation mucoadhesive micelle nanoparticle platform for intrathecal delivery of chemotherapy and small-molecule drugs directly to mucosal surfaces.